The global nasogastric tube market size reached US$ 415.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 560.7 Million by 2028, exhibiting a growth rate (CAGR) of 5.21% during 2023-2028. The rising geriatric population across the globe, rapid technological advancements, increasing prevalence of chronic diseases, implementation of strict regulations by governments and international bodies, and rapid expansion and modernization of the healthcare facilities are some of the major factors propelling the market.
|Market Size in 2022
||US$ 415.6 Million
|Market Forecast in 2028
||US$ 560.7 Million
|Market Growth Rate (2023-2028)
A nasogastric tube refers to a thin, flexible tube used in various medical applications. It is comprised of several components, such as the tube itself, a connector, a lumen to allow content passage, and a guide to enable proper positioning. A nasogastric tube is widely used for feeding, medication administration, gastric decompression, gastrointestinal mobility assistance, gastric content sampling, pH level monitoring, postoperative care, bleeding management, and nutritional assessment support. It offers several benefits, including minimal invasiveness, affordability, patient comfort, adaptability in treatment, and accessibility for both short-term and long-term use.
The implementation of strict regulations by governments and international bodies to enforce standards to ensure product quality, safety, and efficacy is favoring the market growth. In addition, the rapid expansion and modernization of healthcare facilities, which offer more opportunities for the utilization of nasogastric tubes, is positively influencing the market growth. Furthermore, the escalating awareness and education about nasogastric tubes among healthcare providers, patients, and caregivers is contributing to the market growth. Apart from this, the relative affordability and cost-effectiveness of nasogastric tubes compared to other medical procedures, which makes them a preferred choice for both short-term and long-term care, is strengthening the market growth. Moreover, the introduction of favorable insurance coverage and reimbursement policies, which facilitate the adoption of nasogastric tubes, as they ease the financial burden on patients and healthcare providers, is supporting the market growth.
Nasogastric Tube Market Trends/Drivers:
The rising geriatric population across the globe
The escalating geriatric population across the globe is playing a vital role in the nasogastric tube market's growth. In line with this, the widespread prevalence of age-related ailments that require specialized interventions, such as nasogastric tube placement, is contributing to the market growth. Furthermore, the presence of conditions such as difficulty in swallowing, malnourishment, chronic illnesses, or the need for postoperative care in the geriatric population is acting as another growth-inducing factor. Moreover, the rising product adoption as a viable method to administer medications to the geriatric population is positively influencing the market growth.
The rapid technological advancements
The technological advancements in the field of nasogastric tubes are vital in shaping the market. In line with this, recent innovations have led to the creation of more sophisticated, patient-friendly, and efficacious tubes. Furthermore, various advancements, including improvements in materials, such as the use of biocompatible silicone or polyurethane, which provide comfort and minimize irritation, are positively influencing the market growth. Additionally, the introduction of enhanced designs with specialized features that allow more precise placement, thus reducing potential complications, is contributing to the market growth. Moreover, the recent developments in radiological techniques, which aid healthcare providers in proper tube positioning and monitoring, are propelling the market growth. Apart from this, modern technologies are enabling the integration of nasogastric tubes with other medical devices and systems for better patient care, which is further bolstering the market growth.
The increasing prevalence of chronic diseases
The prevalence of chronic ailments such as gastrointestinal disorders, cancer, and diabetes are substantially influencing the demand for nasogastric tubes, as they are pivotal in administering nutrition and medications and providing gastric decompression for patients with chronic ailments. Furthermore, chronic diseases often lead to hospitalization and prolonged medical care, where nasogastric tubes are used as a standard care tool. In addition, they are widely utilized in managing complications arising from surgical procedures, obstructions, or severe illnesses that impact the digestive system. Moreover, the rising focus on early diagnosis and preventive care in chronic conditions, which leads to more significant utilization of medical devices, such as nasogastric tubes, is positively influencing the market growth. As a result, the escalating prevalence of chronic diseases is driving the adoption of nasogastric tubes across various healthcare platforms.
Nasogastric Tube Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global nasogastric tube market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, patient type, indication, and end use.
Breakup by Product:
- Levin Tube
- Salem Sump Tube
The report has provided a detailed breakup and analysis of the market based on the product. This includes levin tube, salem sump tube, and others.
Levin tube is preferred in the market as it offers a simple design, making it easier to use for both healthcare providers and patients. Furthermore, it serves essential purposes, such as feeding, medication administration, and gastric decompression effectively, which contributes to its market dominance. Additionally, the Levin tube is suitable for various applications, including short-term use in hospitals, nursing homes, and home care settings. Apart from this, compared to other types of nasogastric tubes, Levin tubes are more affordable, which appeals to healthcare facilities operating under budget constraints, especially in lower-income regions. Moreover, they are easier to manufacture, owing to a simple design, which results in quicker production and widespread availability throughout the supply chain. In addition, Levin tubes meet the necessary regulatory standards and requirements, making them acceptable for use in many countries and healthcare systems.
Breakup by Patient Type:
Adult holds the largest market share
The report has provided a detailed breakup and analysis of the market based on patient type. This includes adult, pediatric, and geriatric. According to the report, adult represented the largest market segment.
Adult patients are dominating the market due to the prevalence of chronic ailments, such as diabetes, gastrointestinal disorders, and cancer, which often necessitate the use of nasogastric tubes. Furthermore, adults often undergo surgical procedures that may require postoperative care involving nasogastric tubes. In line with this, they assist in recovery by managing gastric contents and providing nutritional support. Besides this, adults constitute a substantial proportion of hospital admissions, especially in cases of emergencies or acute illnesses. The necessity for nasogastric tubes in critical care or prolonged hospital stays is further bolstering the market growth. Apart from this, adult patients tend to have better access to healthcare services, including specialized treatments that employ nasogastric tubes. Moreover, the adoption of a modern lifestyle, which leads to an increase in disorders related to diet and stress, is acting as another growth-inducing factor.
Breakup by Indication:
- Stomach Cancer
- Esophageal Cancer
- IBD (Inflammatory Bowel Disease)
- Chronic Kidney Disease
Esophageal Cancer holds the largest market share
The report has provided a detailed breakup and analysis of the market based on indication. This includes stomach cancer, esophageal cancer, IBD (inflammatory bowel disease), chronic kidney disease, dysphagia, and others. According to the report, esophageal cancer represented the largest market segment.
Esophageal cancer often leads to dysphagia or difficulty in swallowing, as the tumor obstructs or narrows the esophagus. This complication necessitates the use of nasogastric tubes to provide nutritional support. Furthermore, the treatment of esophageal cancer often involves surgery, chemotherapy, and radiation therapy, which may cause side effects and further impair a patient's ability to eat normally. In line with this, nasogastric tubes are widely used to administer nutrients, medications, and fluids to facilitate patient recovery and improve clinical outcomes. Additionally, the increasing incidence of esophageal cancer due to unhealthy diets, smoking, and exposure to certain chemicals is acting as another growth-inducing factor. Along with this, the rising geriatric population, which is highly susceptible to esophageal cancer and may require additional care and medical intervention, including the use of nasogastric tubes, is strengthening the market growth.
Breakup by End Use:
- Hospitals and Nursing Homes
- Home Care
Hospitals and Nursing Homes holds the largest market share.
The report has provided a detailed breakup and analysis of the market based on end use. This includes hospitals and nursing homes and home care. According to the report, hospitals and nursing homes represented the largest market segment.
Hospitals and nursing homes are dominating the market as they are primary care centers that handle a substantial number of patients, including those with chronic illnesses, post-surgical needs, or those requiring specialized care. Furthermore, these facilities cater to various medical conditions that necessitate the use of nasogastric tubes, such as acute care in hospitals to long-term care in nursing homes. Additionally, the presence of trained healthcare professionals in hospitals and nursing homes who have the necessary expertise to place and manage nasogastric tubes is further bolstering the market growth. Moreover, they provide an integrated care approach, where various treatments and supportive procedures, such as the use of nasogastric tubes, are carried out under one roof. In addition, these facilities operate under strict regulatory guidelines and are expected to maintain high standards of patient care.
Breakup by Region:
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
North America exhibits a clear dominance in the market, accounting for the largest nasogastric tube market share.
The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America hosts a sophisticated healthcare system with well-equipped hospitals, clinics, and healthcare providers. The robust infrastructure ensures that medical facilities are equipped with the latest technology, including nasogastric tubes, to provide optimal patient care. Furthermore, the region is a hub for technological innovation and research in the medical field, which is contributing to the development and production of advanced nasogastric tube technologies. Additionally, North America faces a high prevalence of chronic conditions, such as obesity, diabetes, and gastrointestinal disorders, which is further boosting the market growth. Apart from this, the presence of a significant geriatric population, which specialized care and tools, including nasogastric tubes, is contributing to the market growth. Moreover, the imposition of supportive regulations by the regional governments to make nasogastric tube procedures more accessible and affordable is propelling the market growth.
The leading nasogastric tube companies are exploring new materials, design enhancements, and integrating advanced technologies to make nasogastric tubes more effective and comfortable for patients. Furthermore, they are developing nasogastric tubes with specialized features and functions, catering to various medical conditions and patient needs. Additionally, several key players are expanding their presence in emerging markets and strengthening distribution channels to ensure easy accessibility to their products across different regions and healthcare settings. Moreover, they are adhering to stringent regulations and international standards to ensure their products meet or exceed regulatory requirements to maintain trust and credibility. In addition, top companies are forming alliances with healthcare institutions, technology providers, and other stakeholders to leverage complementary strengths and foster innovation. Apart from this, they are providing education and training to healthcare professionals on the proper usage, benefits, and maintenance of nasogastric tubes.
The report has provided a comprehensive analysis of the competitive landscape in the global nasogastric tube market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Angiplast Pvt. Ltd.
- Becton, Dickinson and Company
- Bicakcilar Medical Devices
- Cardinal Health Inc.
- Guangdong Baihe Medical Technology Co. Ltd.
- Hangzhou Formed Medical Devices Co.Ltd.
- Poly Medicure Limited
- Securmed SpA (Delta Med
Nasogastric Tube Market Report Scope:
|Base Year of the Analysis
| Historical Period
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- Patient Type
- End Use
||Levin Tube, Salem Sump Tube, Others
|Patient Types Covered
||Adult, Pediatric, Geriatric
||Stomach Cancer, Esophageal Cancer, IBD (Inflammatory Bowel Disease), Chronic Kidney Disease, Dysphagia, Others
| End Uses Covered
||Hospitals and Nursing Homes, Home Care
||North America, Europe, Asia Pacific, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Angiplast Pvt. Ltd., Becton, Dickinson and Company, Bicakcilar Medical Devices, Cardinal Health Inc., Guangdong Baihe Medical Technology Co. Ltd., Hangzhou Formed Medical Devices Co.Ltd., Poly Medicure Limited, QMD, Securmed SpA (Delta Med, Vygon, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global nasogastric tube market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global nasogastric tube market?
- What is the impact of each driver, restraint, and opportunity on the global nasogastric tube market?
- What are the key regional markets?
- Which countries represent the most attractive nasogastric tube market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the nasogastric tube market?
- What is the breakup of the market based on patient type?
- Which is the most attractive patient type in the nasogastric tube market?
- What is the breakup of the market based on indication?
- Which is the most attractive indication in the nasogastric tube market?
- What is the breakup of the market based on end use?
- Which is the most attractive end use in the nasogastric tube market?
- What is the competitive structure of the global nasogastric tube market?
- Who are the key players/companies in the global nasogastric tube market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the nasogastric tube market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global nasogastric tube market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the nasogastric tube industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.